Gapping up
In reaction to earnings/guidance:
- FDX +5.8% (also authorizes new $5 bln share repurchase program), NX +1.8%, WGO +0.8%
Other news:
- LYEL +4.5% (FDA clears IND application to initiate Phase 1 trial for LYL797)
- NXST +2.9% (FOXA and NXST launch NEXTGEN TV broadcasting in Los Angeles)
- AACI +2.6% (acquires Rezolve Mobile Engagement Platform in $2 bln deal)
- DYAI +2.5% (has entered into a Research, License and Collaboration Agreement with Janssen Biotech, one of the Janssen Pharmaceutical Companies of Johnson & Johnson (JNJ) )
- UIHC +1.9% (UIHC to transition its personal lines insurance business in GA, NC, and SC, to HCI)
- CO +1.8% (rejects non-binding proposal from Alternate Ocean Investment Co)
- NAAC +1.5% (announces business combination with TeleSign)
- UPS +1.5% (in sympathy with strong FDX earnings report)
- EOSE +1.4% (TTI and EOSE sign term sheet regarding supply and collaboration agreement)
- MRK +1.3% (NEJM publishes positive results from its Phase 3 MOVe-OUT trial)
Analyst comments:
- SIX +2.7% (upgraded to Outperform from Neutral at Credit Suisse)
- IRTC +2.5% (upgraded to Overweight from Neutral at JP Morgan)
- IVZ +2.1% (upgraded to Outperform from Market Perform at BMO Capital Markets)
- FXLV +1.7% (upgraded to Overweight from Neutral at JP Morgan)